CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,229,610 | -40.5% | 3,708,101 | +0.2% | 0.00% | – |
| Q2 2023 | $10,476,570 | -71.9% | 3,701,968 | -51.3% | 0.00% | -100.0% |
| Q1 2023 | $37,329,175 | -55.1% | 7,602,683 | -1.7% | 0.00% | -66.7% |
| Q4 2022 | $83,049,521 | +17.0% | 7,732,730 | +2.0% | 0.00% | +50.0% |
| Q3 2022 | $70,972,000 | +5.7% | 7,582,294 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $67,131,000 | -23.1% | 7,352,787 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $87,322,000 | -0.4% | 7,187,124 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $87,683,000 | -20.1% | 7,199,126 | +1.3% | 0.00% | -33.3% |
| Q3 2021 | $109,778,000 | +5.4% | 7,105,389 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $104,115,000 | +30.1% | 7,296,068 | +97.9% | 0.00% | +50.0% |
| Q1 2021 | $80,042,000 | +45.7% | 3,686,965 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $54,955,000 | +16.9% | 3,632,266 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $47,017,000 | -27.1% | 3,694,949 | -2.0% | 0.00% | -33.3% |
| Q2 2020 | $64,490,000 | +39.6% | 3,771,345 | +7.8% | 0.00% | +50.0% |
| Q1 2020 | $46,212,000 | -19.1% | 3,498,244 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $57,132,000 | -11.9% | 3,546,310 | -0.1% | 0.00% | -33.3% |
| Q3 2019 | $64,878,000 | +5.3% | 3,549,152 | +23.9% | 0.00% | 0.0% |
| Q2 2019 | $61,587,000 | +13.5% | 2,864,551 | +3.6% | 0.00% | +50.0% |
| Q1 2019 | $54,276,000 | +49.1% | 2,766,310 | -1.2% | 0.00% | 0.0% |
| Q4 2018 | $36,407,000 | -44.9% | 2,800,605 | +1.5% | 0.00% | -33.3% |
| Q3 2018 | $66,055,000 | +53.9% | 2,758,118 | +23.1% | 0.00% | +50.0% |
| Q2 2018 | $42,920,000 | +60.5% | 2,241,248 | +3.7% | 0.00% | +100.0% |
| Q1 2018 | $26,745,000 | -1.0% | 2,160,406 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $27,018,000 | +12.3% | 2,207,407 | +25.6% | 0.00% | 0.0% |
| Q3 2017 | $24,068,000 | -5.0% | 1,758,073 | +6.8% | 0.00% | 0.0% |
| Q2 2017 | $25,345,000 | -2.4% | 1,646,847 | +16.6% | 0.00% | 0.0% |
| Q1 2017 | $25,968,000 | +66484.6% | 1,412,092 | +33585.4% | 0.00% | – |
| Q4 2016 | $39,000 | +18.2% | 4,192 | +6.4% | 0.00% | – |
| Q3 2016 | $33,000 | +73.7% | 3,938 | 0.0% | 0.00% | – |
| Q2 2016 | $19,000 | +216.7% | 3,938 | +305.6% | 0.00% | – |
| Q1 2016 | $6,000 | – | 971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |